CDEK
← All drugs Report issue

autologous cytokine induced killer cells

Cell therapyexperimental

CIK or Cik may refer to: — Wikipedia

Clinical trial activity

39 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
14
Phase 2
27
Phase 3
4
Phase 4
1

Earliest trial started Dec 1, 2008 (NCT00815321)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2015

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • LymphocytesTissue restoration

    tissue restoration - lymphocytes

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • autologous cik cells
  • autologous cytokine-induced killer cell
  • autologous cytokine induced killer cells
  • cik
  • cik
  • cik cells
  • dc-cik
  • dc-cik cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06389305N/AJun 1, 2024Government of China
NCT05622825Phase 1/Phase 2 (Phase 2)Jan 31, 2023National Taiwan University
NCT04802070Phase 1Jan 11, 2021Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
NCT03782363Phase 1Mar 1, 2020Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna, Italian Sarcoma Group
NCT04292769Phase 3Jan 21, 2020People's Liberation Army of China
NCT04214717N/ADec 31, 2019Qingdao University
NCT03987867Phase 1Jun 1, 2019Tianjin Medical University
NCT03987698Phase 2Jun 1, 2019Tianjin Medical University
NCT03815630Early Phase 1 (Phase 1)Feb 1, 2019Allife Medical Science and Technology Co., Ltd., Henan Medical University, Peking University, The First People's Hospital of Yunan Province
NCT03484962Phase 2Mar 25, 2018Benhealth Biopharmaceutical (Shenzhen) Co., Ltd., Guangzhou University, Jinan University
NCT03757858Phase 1/Phase 2 (Phase 2)Mar 1, 2018Capital Medical University
NCT03393858Phase 1/Phase 2 (Phase 2)Dec 1, 2017Capital Medical University
NCT03158480N/AJun 25, 2017China Medical University
NCT03057340Phase 1Jun 1, 2017Zhejiang University
NCT02766348Phase 2May 1, 2016Jingzhou Central Hospital, Shenzhen Hornetcorn Bio-technology Company, LTD
NCT02491697Phase 2Feb 1, 2016The First People's Hospital of Changzhou
NCT02688686Phase 1/Phase 2 (Phase 2)Feb 1, 2016People's Liberation Army of China
NCT02644863Phase 2Dec 1, 2015Guangzhou Medical University, Shenzhen Hornetcorn Bio-technology Company, LTD
NCT02568748Phase 3Oct 1, 2015Cairo University, Tanta University
NCT02487550Phase 2Aug 1, 2015The First People's Hospital of Changzhou
Showing 20 of 39 trials
Page 1 / 2

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Guangxi Medical UniversityAcademic/Hospital5522010
People's Liberation Army of ChinaGovernment5522009
Shenzhen Hornetcorn Bio-technology Company, LTDFor profit4412014
Capital Medical UniversityAcademic/Hospital3322013
Jinan UniversityAcademic/Hospital3312015
Sun Yat-Sen UniversityAcademic/Hospital3322011
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'AnnaAcademic/Hospital2112020
Bureau of Science and Technology of Guangxi Province, ChinaGovernment2022010
Jingzhou Central HospitalAcademic/Hospital2012014
Qingdao UniversityAcademic/Hospital2122015
The First People's Hospital of ChangzhouAcademic/Hospital2212015
Tianjin Medical UniversityAcademic/Hospital2222019
Allife Medical Science and Technology Co., Ltd.For profit1112019
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.For profit1012018
Cairo UniversityAcademic/Hospital1012015
China Medical UniversityAcademic/Hospital1112017
Government of ChinaGovernment1112024
Guangzhou Medical UniversityAcademic/Hospital1012015
Guangzhou UniversityAcademic/Hospital1012018
Henan Medical UniversityAcademic/Hospital1012019
29 organizations
Page 1 / 2